Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313654005> ?p ?o ?g. }
- W4313654005 endingPage "344" @default.
- W4313654005 startingPage "335" @default.
- W4313654005 abstract "Background Accumulating reports indicate that statins widely prescribed for hypercholesteromia have antineoplastic activity. We hypothesized that because statins inhibit farnesylation of Ras that is often mutated in multiple myeloma (MM), as well as the production of interleukin (IL)-6, a key cytokine in MM, they may have antiproliferative and/or proapoptotic effects in this malignancy. Methods U266, RPMI 8226, and ARH77 were treated with simvastatin (0–30 μM) for 5 days. The following aspects were evaluated: viability (IC 50 ), cell cycle, cell death, cytoplasmic calcium ion levels, supernatant IL-6 levels, and tyrosine kinase activity. Results Exposure of all cell lines to simvastatin resulted in reduced viability with IC 50 s of 4.5 μM for ARH77, 8 μM for RPMI 8226, and 13 μM for U266. The decreased viability is attributed to cell-cycle arrest (U266, G 1 ; RPMI 8226, G 2M ) and cell death. ARH77 underwent apoptosis, whereas U266 and RPMI 8226 displayed a more necrotic form of death. Cytoplasmic calcium levels decreased significantly in all treated cell lines. IL-6 secretion from U266 cells was abrogated on treatment with simvastatin, whereas total tyrosine phosphorylation was unaffected. Conclusions: Simvastatin displays significant antimyeloma activity in vitro. Further research is warranted for elucidation of the modulated molecular pathways and clinical relevance." @default.
- W4313654005 created "2023-01-07" @default.
- W4313654005 creator A5001000879 @default.
- W4313654005 creator A5003143997 @default.
- W4313654005 creator A5004207753 @default.
- W4313654005 creator A5026658735 @default.
- W4313654005 creator A5041346504 @default.
- W4313654005 creator A5091650686 @default.
- W4313654005 date "2004-07-01" @default.
- W4313654005 modified "2023-09-30" @default.
- W4313654005 title "Simvastatin Induces Death of Multiple Myeloma Cell Lines" @default.
- W4313654005 cites W118160759 @default.
- W4313654005 cites W1498308337 @default.
- W4313654005 cites W1498903994 @default.
- W4313654005 cites W1524798625 @default.
- W4313654005 cites W153618619 @default.
- W4313654005 cites W15429299 @default.
- W4313654005 cites W1550810733 @default.
- W4313654005 cites W1652351875 @default.
- W4313654005 cites W1964071961 @default.
- W4313654005 cites W1978278292 @default.
- W4313654005 cites W1992019828 @default.
- W4313654005 cites W1995933366 @default.
- W4313654005 cites W1996777279 @default.
- W4313654005 cites W1996907401 @default.
- W4313654005 cites W2001607257 @default.
- W4313654005 cites W2003661432 @default.
- W4313654005 cites W2004209804 @default.
- W4313654005 cites W2009966520 @default.
- W4313654005 cites W2015112307 @default.
- W4313654005 cites W2015975538 @default.
- W4313654005 cites W2024591105 @default.
- W4313654005 cites W2026048257 @default.
- W4313654005 cites W2029227802 @default.
- W4313654005 cites W2043746123 @default.
- W4313654005 cites W2051256348 @default.
- W4313654005 cites W2059873406 @default.
- W4313654005 cites W2068639674 @default.
- W4313654005 cites W2068798184 @default.
- W4313654005 cites W2071124826 @default.
- W4313654005 cites W2077861214 @default.
- W4313654005 cites W2078070485 @default.
- W4313654005 cites W2079430799 @default.
- W4313654005 cites W2091284006 @default.
- W4313654005 cites W2093944336 @default.
- W4313654005 cites W2098712005 @default.
- W4313654005 cites W2104957053 @default.
- W4313654005 cites W2125149319 @default.
- W4313654005 cites W2145043738 @default.
- W4313654005 cites W2146047031 @default.
- W4313654005 cites W2150565253 @default.
- W4313654005 cites W2161821089 @default.
- W4313654005 cites W2164980141 @default.
- W4313654005 cites W2274360084 @default.
- W4313654005 cites W2322800113 @default.
- W4313654005 cites W2324412866 @default.
- W4313654005 cites W2341279355 @default.
- W4313654005 cites W2474873081 @default.
- W4313654005 doi "https://doi.org/10.1177/108155890405200534" @default.
- W4313654005 hasPublicationYear "2004" @default.
- W4313654005 type Work @default.
- W4313654005 citedByCount "1" @default.
- W4313654005 countsByYear W43136540052023 @default.
- W4313654005 crossrefType "journal-article" @default.
- W4313654005 hasAuthorship W4313654005A5001000879 @default.
- W4313654005 hasAuthorship W4313654005A5003143997 @default.
- W4313654005 hasAuthorship W4313654005A5004207753 @default.
- W4313654005 hasAuthorship W4313654005A5026658735 @default.
- W4313654005 hasAuthorship W4313654005A5041346504 @default.
- W4313654005 hasAuthorship W4313654005A5091650686 @default.
- W4313654005 hasConcept C105696609 @default.
- W4313654005 hasConcept C184235292 @default.
- W4313654005 hasConcept C185592680 @default.
- W4313654005 hasConcept C190283241 @default.
- W4313654005 hasConcept C203014093 @default.
- W4313654005 hasConcept C2776329913 @default.
- W4313654005 hasConcept C2776364478 @default.
- W4313654005 hasConcept C2777553839 @default.
- W4313654005 hasConcept C2778690821 @default.
- W4313654005 hasConcept C29537977 @default.
- W4313654005 hasConcept C31573885 @default.
- W4313654005 hasConcept C42362537 @default.
- W4313654005 hasConcept C502942594 @default.
- W4313654005 hasConcept C53227056 @default.
- W4313654005 hasConcept C54355233 @default.
- W4313654005 hasConcept C55493867 @default.
- W4313654005 hasConcept C62112901 @default.
- W4313654005 hasConcept C62478195 @default.
- W4313654005 hasConcept C71924100 @default.
- W4313654005 hasConcept C81885089 @default.
- W4313654005 hasConcept C86803240 @default.
- W4313654005 hasConcept C95444343 @default.
- W4313654005 hasConcept C98274493 @default.
- W4313654005 hasConceptScore W4313654005C105696609 @default.
- W4313654005 hasConceptScore W4313654005C184235292 @default.
- W4313654005 hasConceptScore W4313654005C185592680 @default.
- W4313654005 hasConceptScore W4313654005C190283241 @default.
- W4313654005 hasConceptScore W4313654005C203014093 @default.